Titan Company Ltd - Quarterly Update: Q4FY23
Titan Company Ltd has announced the quarterly operational update for the period ended March 31, 2023 i.e., Q4FY23.
Stay updated with breaking news from Manufacturing Services Division. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Titan Company Ltd has announced the quarterly operational update for the period ended March 31, 2023 i.e., Q4FY23.
Titan Company Limited has announced the Quarterly Update on various businesses for the period ended December 31, 2022 i.e., Q3FY23.
There is also muted demand for the much-hyped anti-viral drug Molnupiravir, which at least 13 firms are manufacturing including Sun Pharma, Cipla, Dr. Reddy’s, and Aurobindo Pharma, among others.
This agreement, initially centred on Librela, paves the way for development and manufacturing of other molecules in the coming years.
Syngene International Limited announced the signing of a 10- year agreement with leading animal health company, Zoetis, to manufacture the drug...